TR Talks

Description

Geared to an inter-professional community of clinicians, researchers, and trainees, the series is intended to provoke discussion and community building. The Talks, are intended to provide an overview of the health innovation landscape while introducing the ‘tools and competencies’ needed to systematically ‘translate’ science more effectively.

As part of the graduate seminar, LMP 2300: Fundamentals of Translational Research, the discussion series is hosted by Faculty of Medicine’s Translational Research Program (TRP) and the five collaborating Departments participating in the development of the Toronto Translational HUB (Department of Psychiatry, Medicine, Imaging, Surgery, and Paediatrics).

Format:
Each seminar in the series is two hours. During the first hour, a discussion among all the panel discussants and audience about Translational challenges and opportunities will take place. During the second hour, each of the discussants will meet in smaller groups with attendees to continue the conversation and network.

Join our TR Talk mailing list here.

Introduction: Barriers to Innovation

October 8, 2019

5 - 7 pm

TRP Auditorium; 263 McCaul St

Stagnant incentives, structures, culture, accountabilities, and information systems are often discussed as barriers to health innovation.  How can existing barriers can be re-aligned to develop, assess, scale-up, and spread healthcare innovations?

Moderator:

Vivek Goel; Vice-President, Research and Innovation, and Strategic Initiatives 

Panelists:

Bob Bell; Professor of Surgery, University of Toronto

Garth Smith; Vice President, Business Development & Partnerships

Christopher Yip; Dean of the Faculty of Applied Science & Engineering 

Sandy Schwenger; CEO at m-Health Solutions & PatientCare Solutions

Funding Translation

November 5, 2019

5 - 7 pm

TRP Auditorium; 263 McCaul St

Funding high-impact initiatives based on measurable impacts on health outcomes to create value, the spread and scale-up of promising innovations, and sustain successful inventiveness seems like an obvious innovation strategy.  What are the barriers to funding systematic translational research and how can we develop mechanisms that support systematic and value-driven translational?

Moderator:

 

Panelists:

David Naylor; Professor of Medicine and President Emeritus at the University of Toronto

Translating Clinical Insights

December 3, 2019

5 -7 pm

TRP Auditorium; 263 McCaul St

Clinical insights with measurable impacts for improved health outcomes are not always spread, scaled or adopted into best practices in timely and efficient ways.  What are the barriers to deploying clinical insights efficiently and what strategies can be used to improve uptake of health innovations?

Intellectual Property

January 7, 2020

5 -7 pm

TRP Auditorium; 263 McCaul St

Sometimes seen as antiquated and counter-innovation in some sectors, intellectual property systems are extremely significant to health science innovation.  What should you know about IP to protect your hospital and academic contributions, while supporting favourable opportunities for their commercialization?

Moderator:

Gabriella Chan; Yocto Law Professional

Panelists:

Brian Courtney; Clinician Scientist at Sunnybrook and Executive Chairman at Conavi Medical

Paul Santerre; Professor of Biomaterials & Baxter Chair for Health Technology and Commercialization,

Lahav Gil; CEO of Relay Medical Corp.

Implementation in Clinics and Community

February 4, 2020

5 -7 pm

TRP Auditorium; 263 McCaul St

Collaborative, integrated, multi-sectoral and interprofessional value-based care delivery service models based on precision medicine are the magic bullet that will save our healthcare system and it will be done in the comfort of your own home.  Care is moving from the centralized hospital structure to the decentralized community model, the only question is how?

 

Panelists: 

Ronald Cohn; President and CEO at SickKids

Roles of Patients in Research

March 3, 2020

5 -7 pm

TRP Auditorium; 263 McCaul St

The benefits and value of patient engagement and empowerment are continually touted as a research imperative. Can patient engagement translate to patient advocacy that can improve research? How? And what does meaningful patient engagement look like?

 

Panelists:

Pat Furlong; Founding President and CEO Parent Project Muscular Dystrophy (PPMD)

Ron Beleno; Patient and Care-Giver Advocate

Alies Maybee; Co-Founder of Patient Advisors Network 

Failures and Frontiers in TR

April 7, 2020

5 -7 pm

TRP Auditorium; 263 McCaul St

Do [animal] models still matter? Institutions are decreasing their investment in animal facilities in the face of new technologies and continue questioning the translatability of findings in animal testing. More and more institutions are taking a more ethical route. So why are these models still being used? What will replace animal testing?

 

Panelists:

Catharine Whiteside; Executive Director, Diabetes Action Canada 

Robert Sugarman;

Norm Rosenblum, Scientific Director of the CIHR Institute of Nutrition, Metabolism, and Diabetes